Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC

Clinical trial NCT07309952 · RECRUITING

Trial details

NCT number: NCT07309952
Sponsor: Yang Hong
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Non-Small Cell Lung Cancer Stage IIIb Non-small Cell Lung Cancer Stage IIIC Non-Small Cell Lung Cancer

Start date: 2025-12-31
Primary completion: 2027-10-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.